Tumor microenvironment-responsive drug self-delivery systems to treat cancer and overcome MDR  

作　　者：Ling-Mei Li Yi-Pin Xie Yu-Rong Qin Hai-Ping Chu Hui Xie De-Jin Zang Teng Liu 

机构地区：[1]School of Pharmaceutical Sciences and Institute of Materia Medica,Shandong First Medical University and Shandong Academy of Medical Sciences,National Key Laboratory of Advanced Drug Delivery and Release Systems,Key Laboratory for Biotechnology Drugs of National Health Commission(Shandong Academy of Medical Sciences),Key Lab for Rare and Uncommon Diseases of Shandong Province,Jinan,250117,China [2]Department of Computer Science,City University of Hong Kong,Hong Kong,999077,China

出　　处：《Rare Metals》2025年第1期1-33,共33页稀有金属(英文版)

基　　金：supported by the National Natural Science Foundation of China(No.21907059);Shandong Province Chinese Medicine Science and Technology Development Project(No.M-2022258);the Young Scientist Development Foundation of Shandong First Medical University(No.202201-002);the Academic Promotion Program of Shandong First Medical University(Nos.2019LJ003 and 2019QL011).

摘　　要：Tumor microenvironment-responsive drug self-delivery systems utilize tumor microenvironment-responsive chemical bonds to link anti-tumor drugs,exploiting the hydrophilic and hydrophobic properties of different drugs to form amphiphilic prodrug molecules with self-assembly characteristics.Upon stimulation by specific factors in the tumor microenvironment,these amphiphilic prodrug molecules can release drugs at precise sites within the tumor.These strategies significantly increase the drug concentration at the tumor site while effectively reducing the damage of anti-cancer drugs to normal tissues.Owing to the advanced delivery strategies such as synergistic administration and controlled drug release,tumor microenvironment-responsive drug self-delivery systems hold great potential for treating malignant tumors with multidrug resistance(MDR).At the same time,the stimulus-reactivity of metal complexes provides an important opportunity to design site-specific prodrugs that can maximize therapeutic efficacy while minimizing adverse side effects of metal drugs.This innovative drug design complements the tumor microenvironment-responsive self-delivery system,providing more feasible therapeutic strategies and possibilities in the field of cancer therapy and drug delivery.This work provides a comprehensive review of recent advancements in drug self-delivery systems,offering insights into their potential applications in cancer therapy and MDR reversal.

关 键 词：Drug self-delivery system Metal drug Tumor microenvironment response Drug carrier Tumor multidrug resistance 

分 类 号：R73[医药卫生—肿瘤]